Picard Medical Files 8-K Report
Ticker: PMI · Form: 8-K · Filed: Dec 3, 2025 · CIK: 2030617
Sentiment: neutral
Topics: sec-filing, 8-k, disclosure
TL;DR
Picard Medical filed an 8-K, likely containing important updates. Watch for details.
AI Summary
On December 3, 2025, Picard Medical, Inc. filed an 8-K report. The filing primarily concerns Regulation FD disclosures and financial statements/exhibits. No specific material events or financial figures were detailed in the provided excerpt.
Why It Matters
This filing indicates Picard Medical, Inc. is providing updates or disclosures to the SEC, which could contain material information for investors.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing notification and does not contain specific financial or operational risks.
Key Players & Entities
- Picard Medical, Inc. (company) — Registrant
- December 3, 2025 (date) — Date of earliest event reported
- 1992 E Silverlake Tucson AZ , 85713 (address) — Principal executive offices
- (520) 545-1234 (phone_number) — Registrant's telephone number
FAQ
What specific information is being disclosed under Regulation FD?
The provided excerpt does not specify the details of the Regulation FD disclosure.
Are there any new financial statements or exhibits attached to this 8-K filing?
The filing indicates that financial statements and exhibits are included, but their content is not detailed in the excerpt.
What is the primary business of Picard Medical, Inc.?
Picard Medical, Inc. is in the 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS' industry, SIC code 3841.
When was Picard Medical, Inc. incorporated?
Picard Medical, Inc. is incorporated in Delaware.
What is the fiscal year end for Picard Medical, Inc.?
The fiscal year end for Picard Medical, Inc. is December 31.
Filing Stats: 533 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2025-12-03 16:05:27
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share PMI The NYSE American, LL
Filing Documents
- picardmedical_8k.htm (8-K) — 38KB
- picardmedical_ex99-1.htm (EX-99.1) — 8KB
- ex99-1_001.jpg (GRAPHIC) — 9KB
- 0001829126-25-009661.txt ( ) — 222KB
- pmi-20251203.xsd (EX-101.SCH) — 3KB
- pmi-20251203_lab.xml (EX-101.LAB) — 33KB
- pmi-20251203_pre.xml (EX-101.PRE) — 22KB
- picardmedical_8k_htm.xml (XML) — 4KB
01
Item 7.01. Regulation FD Disclosure. On December 3, 2025, Picard Medical, Inc. issued a press release announcing that its CEO, Patrick NJ Schnegelsberg, will present data on the Emperor Total Artificial Heart at the CSI Focus D-HF (Device Therapies in Heart Failure) conference. The conference is scheduled for December 5 and 6, 2025, in Frankfurt, Germany. A copy of the press release is furnished as Exhibit 99.1 and incorporated by reference herein. The information in this report and the exhibits attached hereto shall not be deemed to be "filed" for purposes of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits The following exhibits are being filed herewith: Exhibit No. Description 99.1 Picard Medical, Inc. Press Release dated December 3, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Picard Medical, Inc. By: /s/ Patrick NJ Schnegelsberg Name: Patrick NJ Schnegelsberg Title: Chief Executive Officer Dated: December 3, 2025 2